Doxazosin
Product Images NDC 50090-2154

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 50090-2154). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Table 1 (Doxazosin Fig1)

Table 1 (Doxazosin Fig1)
FDA Label Image

Figure 1 – Study 1 (Doxazosin Fig2)

Figure 1 – Study 1 (Doxazosin Fig2)
Mean increase in maximum urinary flow rate and mean change in total symptom score from baseline were measured in a treatment of unknown nature lasting several weeks. The table includes data indicating the placebo change, the mean change, and duration of treatment. Statistical significance was noted compared to the placebo and baseline. Doxazosi titration was implemented up to a maximum dosage of 8 mg.*
FDA Label Image

Chemical Structure (Doxazosin Str)

Chemical Structure (Doxazosin Str)
FDA Label Image

Label Image (Lbl500902153)

Label Image (Lbl500902153)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.